NJ.com

FDA panel weighs Mevacor's fate as over-the-counter drug

Merck's latest attempt to sell its oldest cholesterol-lowering drug, Mevacor, over the counter without a prescription is once again being questioned at the Food and Drug Administration. In preparation ...
The Motley Fool

Second Chance for Merck's MEVACOR

Yesterday, Merck (NYSE:MRK) licensed the rights to an over-the-counter (OTC) version of its cholesterol-lowering drug MEVACOR to GlaxoSmithKline (NYSE:GSK), but the deal is far from done. Merck has ...
Medscape

FDA Safety Labeling Changes: Hectorol, Mevacor, Pulmicort Respules

Sept. 28, 2005 ( updated Oct. 6, 2005) -- The U.S. Food and Drug Administration (FDA) approved safety labeling revisions in June to advise that doxercalciferol dose reductions are recommended in ...
MM&M

FDA rejects Merck’s Mevacor OTC bid

An FDA advisory panel has rejected Merck’s bid to sell the cholesterol-lowering drug Mevacor without a prescription. The panel voted 10-2 against recommending OTC sales of the drug. The rejection ...
East Bay Times

Mevacor receives setback

WASHINGTON — Government advisers on Thursday rejected Merck & Co.’s bid for over-the-counter sales of Mevacor, the granddaddy of the famed cholesterol-lowering drugs. Too many of the wrong people ...
MM&M

FDA panel considers nonprescription sale of Mevacor

An FDA panel was set to decide on Friday whether they will recommend approval for Merck’s plan to sell a cholesterol-lowering medicine on drugstore shelves without a prescription, Reuters reported.
LAist

Zocor, Lipitor, Pravachol and Mevacor: Probing the effectiveness of statins

In 2009, pharmacists filled over 200 million prescriptions for statins, the drug that’s thought to prevent heart attacks and strokes. And, manufacturers of the drug, more commonly known as Zocor, ...
Washington Times

Advisers to FDA restrict Mevacor

A Food and Drug Administration advisory panel yesterday recommended against over-the-counter sales of a cholesterol drug, saying the risks of using it without a doctor’s supervision were greater than ...
CBS News

FDA Advisers Reject OTC Cholesterol Drug

U.S. government advisers rejected Merck & Co.'s latest bid for over-the-counter sales of Mevacor, the granddaddy of the famed cholesterol-lowering drugs. They said it is too complicated for consumers ...
Medscape

FDA Safety Labeling Changes: Novantrone, Mevacor, Nitro-Dur

July 6, 2005 — The U.S. Food and Drug Administration (FDA) approved in April revisions to safety labeling to advise that use of mitoxantrone is associated with increased risks of cardiotoxicity and ...
NBC News

FDA rejects over-the-counter statin Mevacor

Merck & Co. on Friday said the Food and Drug Administration rejected its application to market an over-the-counter cholesterol drug. The FDA indicated that a 20 milligram dose of Mevacor OTC, or ...